Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease

Published: 12.09.2024

Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals

Published: 16.05.2024

Navamedic welcomes new shareholders

Published: 13.03.2024

Navamedic ASA launches Eroxon®

Published: 12.02.2024

Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region

Published: 23.11.2022

Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation

Published: 20.10.2022